Brand: CBDfx. Report-card status: Concern. CBDfx provides public batch-specific lab records, current return terms, and account-based subscription controls. The strongest current concern is consumer-facing label and product-page consistency in sampled products, including a large CBD potency overage in one named batch and conflicting inventory or shipping copy. A 2022 FDA warning letter is retained as historical context rather than treated as a current-batch finding.
Brand Report Card
| Check | Result | Current evidence |
|---|---|---|
| COA access | Pass | CBDfx maintains public product-specific lab-result pages that list exact batch IDs and report dates. |
| Batch matching | Pass | PP-012 matched Full Spectrum Mixed Berry CBD Gummies 1500mg to batch PV07162025-60; PP-015 separately matched Apple Cider Vinegar Gummies 1500mg to batch PV11292025. |
| Test-panel coverage | Unknown | The sampled PP-012 certificate provided cannabinoid results but not the contaminant panels needed for a brand-wide Pass. |
| Label clarity | Concern | PP-012 found about 1972.92mg CBD in a unit labeled 1500mg, roughly 31.5% above the seller figure. The same seller page also displayed conflicting inventory and restricted-state messaging during the September 2026 check. |
| THC wording | Pass | The September 2026 20-brand audit rated the sampled CBDfx THC wording Pass because current broad-spectrum copy ties THC removal to detectable traces rather than treating a laboratory threshold as a universal drug-test or impairment guarantee. |
| Refund terms | Pass | The current return policy describes a 60-day guarantee for eligible unopened or minimally used products in original packaging, with refund processing details. |
| Subscription cancellation | Pass | The current Subscribe & Save page says customers can pause, change payment information, renew immediately, or cancel through My Account. |
| Customer service test | Not Tested | CBDCafe did not contact CBDfx customer service for BR-012. |
| FDA warning-letter check | Concern | FDA issued a November 16, 2022 warning letter to Newhere Inc dba CBDFX that referenced multiple CBDfx products, including Mixed Berry Gummies 1500mg. This is historical regulatory context, not a finding about the reviewed 2026 batch. |
| Evidence freshness | Pass | Lab-result pages, current seller policies, sampled Product Passports, and the FDA record were checked September 5, 2026. |
COA and Exact-Batch Access
CBDfx’s lab-result pages identify exact product batches and dates. PP-012 matched Full Spectrum Mixed Berry CBD Gummies 1500mg to batch PV07162025-60, dated April 30, 2026. PP-015 separately tracked Apple Cider Vinegar Gummies to batch PV11292025.
View the Mixed Berry lab-result page · Read PP-012 · Read PP-015
Label and Product-Page Consistency
The reviewed Mixed Berry certificate reported approximately 1972.92mg CBD per unit and 65.76mg per serving against a 1500mg package and 50mg serving label. That is about 31.5% above the seller figures and is recorded as a label-documentation Concern.
During the same September 2026 check, the current product page also displayed both “In stock, ready to ship” and “Sold out” messaging and showed two different restricted-state lists. CBDCafe records those conflicts as documentation issues and does not infer actual inventory or legal shipping eligibility from contradictory seller copy.
Refund and Subscription Terms
CBDfx’s current return policy describes a 60-day guarantee for eligible unopened or minimally used products in original packaging. The current Subscribe & Save page advertises recurring savings and says customers can pause, change payment information, renew immediately, or cancel through their account.
Historical FDA Warning Letter
FDA issued a warning letter to Newhere Inc dba CBDFX on November 16, 2022. The letter referenced several CBDfx products and historical marketing or product-positioning issues, including Mixed Berry Gummies 1500mg.
This is relevant regulatory history. It does not establish that current 2026 batches, labels, or claims repeat the same issues.
How to Verify CBDfx Documentation Now
- Open the current CBDfx lab-results page and confirm the exact product and batch ID you are checking.
- Match the package strength and batch to the report before comparing cannabinoid results or seller wording.
- Recheck current inventory, shipping restrictions, refund terms, and subscription controls because seller pages can change.
- Open the related CBDCafe Product Passport for the named batch before treating this brand-level summary as product-specific evidence.
Review Scope
- Report Card ID: BR-012
- Review level: Documentation Review
- Commercial relationship: No commercial tie recorded
- Customer service test: Not Tested
- Last checked: September 5, 2026
- Current status: Concern
Related: All Brand Report Cards · CBD Return Policies and Subscription Terms · CBD Product Passports · CBD COA Access and Label Quality Report